Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 3
2013 8
2014 17
2015 19
2016 12
2017 9
2018 2
2019 1
2020 4
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Results by year
Filters applied: . Clear all
Page 1
Current pathogenic Escherichia coli foodborne outbreak cases and therapy development.
Yang SC, Lin CH, Aljuffali IA, Fang JY. Yang SC, et al. Among authors: aljuffali ia. Arch Microbiol. 2017 Aug;199(6):811-825. doi: 10.1007/s00203-017-1393-y. Epub 2017 Jun 9. Arch Microbiol. 2017. PMID: 28597303 Review.
Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP, Aljuffali IA, Fang JY. Yu HP, et al. Among authors: aljuffali ia. Curr Pharm Des. 2017;23(3):481-494. doi: 10.2174/1381612822666161027113654. Curr Pharm Des. 2017. PMID: 28292243 Review.
Nanomedical strategies for targeting skin microbiomes.
Aljuffali IA, Huang CH, Fang JY. Aljuffali IA, et al. Curr Drug Metab. 2015;16(4):255-71. doi: 10.2174/1389200216666150812124923. Curr Drug Metab. 2015. PMID: 26264194 Review.
Pharmaceutical companies' views on a health technology assessment (HTA) entity in Saudi Arabia.
Al-Omar HA, Attuwaijri AA, Aljuffali IA. Al-Omar HA, et al. Among authors: aljuffali ia. Saudi Pharm J. 2020 Jun;28(6):662-668. doi: 10.1016/j.jsps.2020.04.006. Epub 2020 Apr 23. Saudi Pharm J. 2020. PMID: 32550796 Free PMC article.
Exploring the status and views of managed entry agreements in Saudi Arabia: mixed-methods approach.
Al-Omar HA, Alghannam HH, Aljuffali IA. Al-Omar HA, et al. Among authors: aljuffali ia. Expert Rev Pharmacoecon Outcomes Res. 2020 Jul 13:1-9. doi: 10.1080/14737167.2020.1792295. Online ahead of print. Expert Rev Pharmacoecon Outcomes Res. 2020. PMID: 32658625
The codrug approach for facilitating drug delivery and bioactivity.
Aljuffali IA, Lin CF, Chen CH, Fang JY. Aljuffali IA, et al. Expert Opin Drug Deliv. 2016 Sep;13(9):1311-25. doi: 10.1080/17425247.2016.1187598. Epub 2016 May 27. Expert Opin Drug Deliv. 2016. PMID: 27159251 Review.
What local experts expect from a health technology assessment (HTA) entity in Saudi Arabia: workshop conclusions.
Al-Omar HA, Attuwaijri AA, Aljuffali IA. Al-Omar HA, et al. Among authors: aljuffali ia. Expert Rev Pharmacoecon Outcomes Res. 2020 Feb;20(1):99-104. doi: 10.1080/14737167.2019.1610398. Epub 2019 Apr 29. Expert Rev Pharmacoecon Outcomes Res. 2020. PMID: 31032687
Cutaneous delivery of natural antioxidants: the enhancement approaches.
Aljuffali IA, Hsu CY, Lin YK, Fang JY. Aljuffali IA, et al. Curr Pharm Des. 2015;21(20):2745-57. doi: 10.2174/1381612821666150428125428. Curr Pharm Des. 2015. PMID: 25925121 Review.
Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis.
Bazarbashi S, De Vol EB, Maraiki F, Al-Jedai A, Ali AA, Alhammad AM, Aljuffali IA, Iskedjian M. Bazarbashi S, et al. Among authors: aljuffali ia. Pharmacoecon Open. 2020 Dec;4(4):625-633. doi: 10.1007/s41669-020-00211-0. Pharmacoecon Open. 2020. PMID: 32291726 Free PMC article.
Delivery and targeting of nanoparticles into hair follicles.
Fang CL, Aljuffali IA, Li YC, Fang JY. Fang CL, et al. Among authors: aljuffali ia. Ther Deliv. 2014;5(9):991-1006. doi: 10.4155/tde.14.61. Ther Deliv. 2014. PMID: 25375342 Review.
61 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback